SCHEMBL6730308

SCHEMBL6730308

Cc1cccc(-c2noc(C(F)F)c2-c2ccc(S(C)(=O)=O)c(F)c2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 6/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
NPC1 O15118 1/20 0.36
TP53 P04637 1/20 0.36
RAB9A P51151 1/20 0.36
ALDH1A1 P00352 1/20 0.35
ELANE P08246 1/20 0.35
TRPV1 Q8NER1 1/20 0.35
HTR7 P34969 1/20 0.34
PIK3CD O00329 1/20 0.34
PIK3CA P42336 1/20 0.34
PIK3CB P42338 1/20 0.34
PIK3CG P48736 1/20 0.34
MAPK14 Q16539 2/20 0.34
NR1H2 P55055 1/20 0.34
NR1H3 Q13133 1/20 0.34
LMNA P02545 1/20 0.33
GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6723085 0.91 PTGS2 (0.42) PTGS2MEN1KMT2ASMN1; SMN2NPC1
SCHEMBL6726701 0.90 PTGS2 (0.38) PTGS2ALDH1A1HTR7MAPK14
SCHEMBL6722938 0.90 PTGS2 (0.39) PTGS2MEN1KMT2ANPC1ALDH1A1
SCHEMBL6722731 0.89 PTGS2 (0.42) PTGS2KMT2AALDH1A1PIK3CDPIK3CA
SCHEMBL6723710 0.89 PTGS2 (0.45) PTGS2NPC1RAB9AALDH1A1MAPK14
SCHEMBL6719025 0.88 PTGS2 (0.43) PTGS2KMT2ARAB9ATRPV1HTR7
SCHEMBL6719286 0.88 PTGS2 (0.34) PTGS2MEN1KMT2AALDH1A1ELANE
SCHEMBL6722025 0.88 PTGS2 (0.39) PTGS2PIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL6725529 0.88 PTGS2 (0.38) PTGS2PIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL6723645 0.87 PTGS2 (0.40) PTGS2PIK3CDPIK3CAPIK3CBPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040092552-A1 2-Fluorobenzenesulfonyl compounds for the treatment of inflammation PHARMACIA CORPORATION 2004-05-13 US disclosed
EP-1296971-A2 2-FLUOROBENZENESULFONYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION Pharmacia Corporation (US) 2003-04-02 EP disclosed
US-20020183362-A1 2-Fluorobenzenesulfonyl compounds for the treatment of inflammation PHARMACIA CORPORATION 2002-12-05 US disclosed
WO-2001081332-A2 2-FLUOROBENZENESULFONYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION PHARMACIA CORPORATION (US) 2001-11-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020183362-A1 2-Fluorobenzenesulfonyl compounds for the treatment of inflammation FPR2, FPR1, PTGES2 PTGS2 5/4885MEN1 4391/4885KMT2A 1836/4885
US-20040092552-A1 2-Fluorobenzenesulfonyl compounds for the treatment of inflammation FPR2, PTGES2, FPR1 PTGS2 5/4885MEN1 4477/4885KMT2A 2035/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.